Dr. Kumarswamy Gangadharayya Kallur

Medical Degrees:

• MBBS - Karnataka Medical College, Hubli (1985)
• DRM (Diploma in Radio Medicine) - Tata Memorial Hospital, Mumbai (1987)
• MD (Radiation Oncology) - Kasturba Medical College, Mangalore (1994)

Certifications & Accreditations:

• Former President of the Southern Chapter of Society of Nuclear Medicine (India)
• Former President of the Association of Nuclear Medicine Physicians of India (2010-2012)

Major Cancer Types Treated:

• Involved in diagnostic imaging and theranostic treatment planning for a wide range of cancers, including:
• Thyroid Cancer
• Prostate Cancer
• Breast Cancer
• Head and Neck Cancer
• Lung Cancer
• Rectal Cancer
• Hepatocellular Carcinoma
• GBM (Glioblastoma Multiforme)

Sub-specialties:

• General Nuclear Medicine
• PET CT Imaging
• Molecular Imaging
• Theranostics
• Radiopharmacy
• Radionuclide Imaging
• SPECT Imaging

Advanced Procedures Performed:

• PET CT Scans (FDG-PET, Ga68 PSMA PET/CT)
• Theranostic applications using radiopharmaceuticals
• Radioiodine therapy for thyroid cancer
• Advanced molecular imaging techniques
• Radiopharmaceutical unit management

Current & Past Hospital Affiliations:
Current Affiliations:

• Director of Molecular Imaging and Nuclear Medicine - HCG Cancer Centre, DR BLR & KR BLR (Bangalore)
• Managing Director at Healthcare Global Enterprises Ltd

Past Affiliations:

• Established the Nuclear Medicine Department at HCG in 1996.

Academic & Research Roles:

• Authored several national and international publications (55 publications).
• Presented papers at various conferences around the world.
• Former President of the Southern Chapter of SNM of India.
• Former President of the Association of Nuclear Medicine Physicians of India (ANMPI) for the year 2010-2012.

Key Achievements & Contributions:

• Established the Nuclear Medicine Department at HCG in 1996.
• Played a significant role in establishing India’s first FDA-compliant Cyclotron and PET radiopharmaceutical unit.
• Founder member of the Association of Nuclear Medicine Physicians of India (ANMPI).
• Contributed to numerous research papers and presentations, advancing the field of nuclear medicine and oncology.

Published Papers in Medical Journals: (Selected Recent Publications)

• "Decoding anterior tongue carcinoma beyond TNM: Indian multi-centric, real-world data on molecular profiling and immunity in relation to clinical outcome—A divide, dive deep, and conquer approach." Article. (Jun 2025).
• "3203: Interim PETCT IGOART Pelvic Malignancies: A Guide to Precise Futuristic Dose Escalation Strategies." Article. (May 2024).
• "Efficacy of SBRT in High Volume Metastatic Carcinoma Breast – A Berry Picking Approach in the Era of High Precision Radiotherapy." Article. (Nov 2022).
• "Dose Escalation Using Cyberknife Boost in Locally Advanced High Risk Prostatic Carcinoma –A Comparative Study with Historic Cohort Receiving Conventional Fractionated Dose Escalated External Beam Radiotherapy." Article. (Jul 2021).
• "Case Series Pleomorphic Variant of Primary Breast Liposarcoma: A Case Report of Rare Entity with Radiopathological Review." Article. (Jun 2021).
• "Residual Thyroid Tissue on Postoperative Diagnostic 131 I Radioactive Whole-Body Scan After Surgery in Differentiated Thyroid Cancer: A Tertiary Referral Centre Experience." Article. (Jun 2021).
• "Cancer Ther Oncol Int J FDG-PET Metabolic Vs CT Monitoring of Tumor Response to Anterior Chemotherapy in Breast Carcinoma-The Uncertainties." Article. (Jun 2021).
• "Role of Fibroblast Activated PET-CT Scan to Evaluate Response to Eribulin in HER2 NEU Positive Metastatic Breast Cancer-A Case Report Case Report." Article. (Nov 2020).
• "Preoperative Chemoradiation In Rectal Cancer: Predicting Complete Pathological Responders Through Metabolic Imaging." Article. (Nov 2020).
• "Comparison of Response and Survival in Patients of Metastatic Non-Small-Cell Lung Cancer Receiving SBRT and Concurrent Immunotherapy-SBRT." Article. (Nov 2020).
• "Impact of postoperative diagnostic 131 I radioactive whole-body scans in the management of differentiated thyroid cancer after complete surgery." Preprint. (May 2020).
• "Diagnostic evaluation of PET CT, USG Neck & FNAC in clinically N0 neck." Preprint. (May 2020).
• "SBRT and Hyperthermia in Hepatocellular Carcinoma - Tertiary Cancer Centre Experience." Article. (Sep 2019).
• "Survival Analysis of GBM Patients Treated with SIB Chemoradiotherapy Followed By SBRT-CK BOOST." Article. (Sep 2019).
• "Utility of EBUS-TBNA in PET-positive mediastinal lymph nodes in subjects with extra-thoracic malignancy." Article. (Mar 2019).
• "Role of Positron Emission Tomography/Computed Tomography in Preoperative Assessment of Carcinoma Endometrium—a Retrospective Analysis." Article. (Nov 2018).
• "Functional, Radiological Imaging and Biochemical (PET PSMA, MRI, ADC, PSA) Response and its Correlation in Low and Intermediate Risk Prostate Cancer Treated with SBRT by Robotic Radiosurgery Alone." Article. (Nov 2018).
• "Evaluation of Interim PET CT Scan As Predictor for Early Response to Chemoradiotherapy in Locally Advanced Head and Neck Cancer Retrospective Study." Article. (Nov 2018).
• "EP-1566: Metabolic response assessment using Ga68 PSMA PETCT in HR organ confined Prostate cancer post IGIMRT." Article. (Apr 2018).
• "PET-CT high-SUV mediastinal lymph nodes (MLN) in primary or treated extrathoracic malignancy – “Not all that lights up is malignant”." Conference Paper. (Sep 2017).
• "PET-CT Based Non-Invasive Radiomic Biomarkers as a Part of Precision Medicine Initiative to Predict Local Recurrences in Oral Cancers." Article. (Aug 2017).
• "Small-Sized Thyroid Cancers—a Single Institutional Experience in India." Article. (Jun 2017).
• "Clinical utility of gallium-68 PSMA PET/CT scan for prostate cancer." Article. (Apr 2017).
• "109P Impact of FDG PET-CT in response evaluation of different molecular subtypes of locally advanced breast cancers post dose dense neoadjuvant chemotherapy." Article. (Dec 2016).

Notable Cases Handled:
Dr. Kumarswamy G. Kallur has been pivotal in hundreds of thousands of patient cases by providing accurate diagnostic imaging through PET CT scans and guiding theranostic treatments. His role in establishing and leading a cutting-edge Nuclear Medicine Department has directly contributed to improved patient outcomes and precise cancer management.

Patient Testimonials:

• "Thanks to Dr. Kallur's expertise with the PET CT scan, my cancer was accurately staged, allowing for a precise treatment plan. He's truly a leading Nuclear Medicine Specialist." - Vivek R.
• "Dr. Kallur's work in Nuclear Medicine is phenomenal. His guidance with my theranostic treatment for prostate cancer has been life-changing. I highly recommend him." - Arjun S.
• "The clarity and detail provided by the molecular imaging under Dr. Kallur's direction were incredible. It made a huge difference in understanding my treatment options." - Priya L.

Patient-Centred Care: Dr. Kallur is deeply committed to providing personalised care by creating a comfortable environment for his patients. He ensures that advanced technology and therapies, such as PET CT imaging and theranostics, are utilised effectively for accurate diagnosis and tailored treatment, always keeping the patient's well-being at the forefront.

Technology & Innovation: A pioneer in the field, Dr. Kallur's career is marked by significant contributions to molecular imaging and nuclear medicine in India. His instrumental role in establishing India’s first FDA-compliant Cyclotron and PET radiopharmaceutical unit demonstrates his unwavering dedication to leveraging cutting-edge technology and innovation for precise cancer diagnosis and treatment. His expertise spans PET/CT, SPECT, and radiopharmaceuticals

For appointment booking and to get a personalised cost estimate, you can connect with the Cancer Rounds team.

Language Support: The Cancer Rounds team typically offers support for international patients, including language services (English and Hindi) to ensure clear communication during complex molecular imaging and theranostic procedures with a top Nuclear Medicine specialist in India.

Visa & Travel Assistance: The Cancer Rounds team assists with visa processes, travel arrangements, airport transfers, and accommodation, providing comprehensive support for international patients seeking advanced PET CT imaging or nuclear medicine treatments.

Pre-treatment Virtual Consultations: Telemedicine capabilities are available for initial discussions, review of medical records, and second opinions, allowing international patients to access Dr. Kumarswamy G. Kallur's vast expertise in Nuclear Medicine before travelling to India.